Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
ASM Research Chemicals, a contract research and development services provider specialized in organic chemistry, is launching its new development pack (referred to as DevPack) service intended for active pharmaceutical ingredients (APIs) manufacturing...
read more
Celerion has announced that effective January 1, 2016, Assign Clinical Research, headquartered in Vienna, Austria, has joined Celerion, further expanding their global presence and capabilities in the conduct of complex early clinical studies.
read more
Wednesday, April 22, 2020
Assistek announced the release of its novel web-based eCOA solution to support remote data collection for patients and sites due to the COVID-19 pandemic.
read more
Friday, December 01, 2017
Astellas Pharma and Mitobridge announced Astellas has exercised its exclusive option right to acquire Mitobridge under the amended terms of the October 2013 partnership agreement.
read more
Astellas Pharma Inc. announced that the FDA has placed a clinical hold on the FORTIS Phase 1/2 trial following the occurrence of a serious adverse event (SAE) of peripheral sensory neuropathy in one of the trial participants.
read more
Wednesday, January 24, 2018
Astellas Pharma has completed the acquisition of Mitobridge.
read more
Astellas Pharma Inc. and DigiTx Partners LLC announced that Astellas has launched DigiTx Partners, a digital health investment company in partnership with MPM Capital, Inc. DigiTx Partners will invest in the digital health space broadly, with a ...
read more
AIRM and Universal Cells have entered into an exclusive worldwide license agreement to research, develop and commercialize a novel cell therapy for an undisclosed indication.
read more
Wednesday, August 12, 2015
Asterand Bioscience has announced the acquisition of AdeptBio LLC, a Memphis-based biobank organization, which specializes in procurement of human tissue specimens.
read more
Wednesday, February 15, 2017
Asterand Bioscience has announced a partnership with MolecularMD to combine MolecularMD’s expertise as a provider of molecular diagnostics products and services with Asterand Bio’s drug target and candidate validation capabilities.
read more
Wednesday, February 17, 2016
Asterand Bioscience has been awarded a five-year, $6.5M contract from the National Institutes of Health (NIH) to provide oncology specimens with associated clinical data to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).
read more
Avania, a full-service global MedTech contract research organization (“CRO”), announced that Astorg has acquired a majority stake in the company.
read more
Astorg and International Chemical Investors Group (ICIG) have signed a binding agreement whereby Astorg will acquire CordenPharm from ICIG. As part of the transaction, the founders will take the opportunity to reinvest as partners with Astorg.
read more
Tuesday, January 27, 2026
Astoriom has expanded its sample management capabilities in the US with the acquisition of Precision Stability Storage. This acquisition marks a strategic expansion of Astoriom’s footprint in North America, strengthening its presence in high-growth ...
read more
Thursday, January 09, 2025
Astraveus SAS announced the successful end-to-end production of CAR-T cells within a microfluidic benchtop system. Astraveus has been able to demonstrate the potential of its unique microfluidic cell therapy processing approach, which has the ability...
read more